Theseus Pharmaceuticals Inc (THRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access THRX quarterly Balance Sheets →
The data below summarizes Theseus Pharmaceuticals Inc's balance sheet position from to Dec 31 2022, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Dec 31 2021)
Assets
Cash & cash equivalent94.61
Available-for-sale Securities, Debt Securities, Current MA103.37
Cash & Short-term Investments197.00
Prepaid Expense And Other Assets Current4.14
Total Current Assets202.12
Equipment/Property/Plant Net0.42
Long-term investments13.82
Other Assets, Noncurrent7.00
Total Assets222.45
Liabilities
Accounts Payable, Current AC4.97
Other Liabilities, Current6.16
Total Current Liabilities11.13
Total Long-term Debt0.00
Other liabilities, Noncurrent3.70
RestrictedStockLiabilityNoncurrent0.47
Operating Lease Liability Current5.41
Total Liabilities14.83
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock320.18
Retained Earnings / Accumulated Deficit-112.19
Other Equity-0.39
Common Stockholder's Equity207.62
Total Stockholder's Equity207.62
Liabilities & Stockholder's Equity222.45
4 historic quarters locked

Sign in to unlock the full Theseus Pharmaceuticals Inc balance sheet history.

About Theseus Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001745020-23-000080

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.